StockData

Nutex Health Inc. (NUTX) stock

NUTXNasdaqServices-Business Services, NECFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Nov 5, 2026Score 15/3067% below fair value
$189.19+2.94 (+1.58%)

Close on Nov 11, 2026Market cap $1.30BP/E 8.1Yield –

Nutex Health Inc. saw revenue fall 18.8% to $796.53M over the twelve months to Sep 30, 2026. Operating income fell 13.4% to $311.00M, moving the operating margin from 36.6% to 39.0%. Free cash flow was $248.10M, up 40.7% from a year earlier. At the latest close the market valued the company at $1.30B, 8.1 times its earnings.

Revenue
$796.53M
-18.8% vs. a year earlier
Operating income
$311.00M
-13.4% vs. a year earlier
Free cash flow
$248.10M
+40.7% vs. a year earlier
EPS, diluted
$23.35
+21.2% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026

Valuation

Market cap
$1.30B
P/E ratio
8.1
Price to sales
1.63
Price to book
2.97
Dividend yield
–
Free cash flow yield
19.15%

Fundamentals

Revenue
$796.53M
Net income
$164.71M
EPS, diluted
$23.35
Free cash flow
$248.10M
Book value per share
$61.85
Diluted shares
7M

Trading

Next earnings
Mar 4, 2027 (estimated, during market hours)
Previous close
$186.25
Open
$189.90
Day's range
$187.00 – $196.69
Volume
98,636
Average volume (20 days)
134,551
Index membership
Russell 2000 (since Jun 2025), Russell 3000 (since Aug 2025)
Beta (5 years)
1.86
52-week range
$83.99 – $226.16
RSI (14 days)
45.8
Volatility (1 year)
90.7%
Relative volume
0.67×
WACC
14.1%

On 3 of our idea lists: Magic Formula, Undervalued and financially sound, Most shorted (a warning list)

Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.

Market cap history

Month-end market cap since 2019, using shares outstanding reported at the time

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 11, 2026. The S&P 500 is measured by the SPY fund.

PeriodNUTXS&P 500DifferenceNUTX per yearS&P 500 per year
1 month-8.3%-2.4%−5.9 pts
3 months+13.7%-1.2%+14.8 pts
Year to date+14.9%+12.3%+2.6 pts
1 year+69.0%+12.4%+56.5 pts
3 years+425.6%+78.8%+346.7 pts+73.9%+21.4%
5 years-70.7%+75.2%−145.8 pts-21.8%+11.9%

Fifteen years at a glance

Fiscal years 2011 to 2025 and trailing twelve months, USD

Revenue

$796.53M-18.8% YoY

Gross profit

$380.67M-29.5% YoY

Operating income

$311.00M-13.4% YoY

Net income

$164.71M+36.5% YoY

EPS, diluted

$23.35+21.2% YoY

Free cash flow

$248.10M+40.7% YoY
Reported periodTrailing twelve months

Press releases

Releases Nutex Health filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Nutex Health

Services-Business Services, NEC

Nutex Health Inc. is a physician-led healthcare services and operations company. It structures its operations into three primary segments: the hospital division, the population health management division, and the real estate division. Through its hospital division, the company develops and operates micro-hospitals, specialty hospitals, and hospital outpatient departments that provide emergency room care, inpatient treatment, behavioral health, and ancillary services including diagnostic imaging, laboratories, and onsite pharmacies. The population health management division organizes and manages provider networks known as independent physician associations via a management services organization. The company serves patients seeking emergency and primary medical care, receiving reimbursement primarily from health insurers, federal agencies, and patient cost-sharing payments.

Company profile, executives and history

Nutex Health stock: common questions

What is Nutex Health's stock price?

NUTX closed at $189.19 on Nov 11, 2026, up 1.58% on the day. Over the past 52 weeks it traded between $83.99 and $226.16.

What is Nutex Health's market cap?

Nutex Health was worth $1.30B at the close on Nov 11, 2026: the share price times the diluted shares outstanding.

What is NUTX's P/E ratio?

NUTX trades at 8.1 times earnings, based on diluted earnings per share of $23.35 over the twelve months to Sep 30, 2026.

How much revenue does Nutex Health make?

Nutex Health reported revenue of $796.53M for the twelve months to Sep 30, 2026, down 18.8% from a year earlier.

Does Nutex Health pay a dividend?

No. Nutex Health has not paid a cash dividend over the last twelve months.

When does Nutex Health report earnings next?

Nutex Health is expected to report Q4 FY2026 results on Mar 4, 2027, during market hours. The date is estimated from its past reporting pattern until the company confirms it.

How has NUTX stock performed over the past year?

Including dividends, NUTX returned +69.0% over the past year, against +12.4% for the S&P 500.

Who are Nutex Health's competitors?

Companies most similar to Nutex Health by business, industry and size include CTEV, PHR, HQY, MAX, PRTH.

See a number that looks wrong?